VOLITIONRX LTD — Director's Dealing 2020

Dec 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-12-01

Reporting Person: Butera Salvatore Thomas (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-01	Common Stock	A	15000	—	Acquired	15000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct

Footnotes

F1: Dr. Butera received restricted stock units subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 12/01/21 and 12/01/22, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2: These shares of Common Stock are jointly owned by Dr. Butera and his spouse.